Compare Tesla, Inc. (TSLA) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance

Tesla, Inc.Trade

State Street SPDR S&P Biotech ETFTrade

Price performance (Past 24H)

Key statistics

Tesla, Inc. vs State Street SPDR S&P Biotech ETF — how do they compare? Tesla, Inc. trades at $379.12 (market cap $1.39T), while State Street SPDR S&P Biotech ETF trades at $154.43. The key difference: State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, Tesla, Inc. nearer its low. Which is the better fit depends on your goals.

	TSLA	XBI
Market Cap	$1.39T	—
Sector	Consumer Cyclical	Broad Market / Factor
52-Week High	$489.88	$164.28
52-Week Low	$302.63	$85.16
Enterprise Value	$1.36T	—

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Tesla, Inc.

Tesla (TSLA) trades at $378.88, down 0.51% with a bearish technical outlook. The stock faces valuation concerns with a P/E of 339 and declining profitability margins, though recent earnings beat expectations. Cash flow remains positive despite heavy capital investments. European regulatory approval for driver-assistance software and German sales growth provide optimism, but competition and slowing auto business present challenges.

Tesla's outlook balances innovation potential against execution risks. The stock offers growth exposure to AI and autonomy but carries premium valuation and competitive pressures. Near-term catalysts include Q2 earnings and robotaxi developments, while margin compression and market sentiment shifts represent key investor risks.

State Street SPDR S&P Biotech ETF

No Aura AI signal available yet.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

TSLA

Roundhill Magnificent Seven ETF offers equal exposure to top 7 mega-cap tech stocks but with higher risk and cost.24/7 Wall Street · 8 hours agoNeutral Northrop Grumman CEO hints space robots could be weaponized, leaving decision to US government.Forbes · 8 hours agoBullish Options traders expect Tesla's biggest post-earnings move in a year, with a 5.76% price swing implied.CNBC · 9 hours agoNeutral View details →

XBI

Healthcare ETFs lead State Street's top 5 performers with pharma fund gaining 11.7% in the past monthETF Trends · 4 days agoBullish View details →

About Tesla, Inc.

Tesla Inc. designs, manufactures, and sells high-performance electric vehicles and electric vehicle powertrain components. The Company owns its sales and service network and sells electric power train components to other automobile manufacturers. Tesla serves customers worldwide.

About State Street SPDR S&P Biotech ETF

XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.